NCT04485169View on ClinicalTrials.gov

Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
COVID-19Cytokine Release Syndrome
Interventions
PROCEDURE

Therapeutic Plasma Exchange

a. 1-1.5 plasma volume exchange, 2/3rd plasma should be replacing with FFP to avoid coagulopathy, adequate dieresis to prevent volume overload, 1-5 sessions in total, 1 session daily

Trial Locations (1)

46000

Pak Emirates Military Hospital, Rawalpindi

All Listed Sponsors
collaborator

Pak Emirates Military Hospital Rawalpindi

UNKNOWN

lead

UNICEF

OTHER

NCT04485169 - Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; | Biotech Hunter | Biotech Hunter